Aspire Private Capital, LLC Champions Oncology, Inc. Call Options Transaction History
Aspire Private Capital, LLC
- $376 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CSBR
# of Institutions
29Shares Held
5.67MCall Options Held
2.6KPut Options Held
9.2K-
Battery Management Corp. Boston, MA2.42MShares$11.7 Million2.62% of portfolio
-
Nea Management Company, LLC Timonium, MD1.71MShares$8.31 Million0.59% of portfolio
-
Tocqueville Asset Management L.P. New York, NY685KShares$3.32 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny125KShares$604,7510.0% of portfolio
-
Black Rock Inc. New York, NY116KShares$561,0620.0% of portfolio
About CHAMPIONS ONCOLOGY, INC.
- Ticker CSBR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,522,400
- Market Cap $65.6M
- Description
- Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...